Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

NBY

Novabay Pharmaceuticals Inc

Apr 23 • 04:00PM ET

0.0770

Dollar change +0.0045
Percentage change 6.21	%

Healthcare • Biotechnology • USA • AMEX

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-3.31	Insider Own	0.04%	Shs Outstand	36.06M	Perf Week	-3.14%
Market Cap	2.78M	Forward P/E	3.08	EPS next Y	0.03	Insider Trans	0.00%	Shs Float	36.05M	Perf Month	-43.47%
Income	-16.70M	PEG	-	EPS next Q	-0.15	Inst Own	3.30%	Short Float	1.99%	Perf Quarter	-52.17%
Sales	14.73M	P/S	0.19	EPS this Y	93.18%	Inst Trans	2.93%	Short Ratio	0.20	Perf Half Y	-78.00%
Book/sh	0.12	P/B	0.63	EPS next Y	109.26%	ROA	-75.81%	Short Interest	0.72M	Perf Year	-95.06%
Cash/sh	0.09	P/C	0.89	EPS next 5Y	-	ROE	-139.03%	52W Range	0.06 - 1.52	Perf YTD	-62.25%
Dividend Est.	-	P/FCF	-	EPS past 5Y	24.47%	ROI	-377.59%	52W High	-94.93%	Beta	2.06
Dividend TTM	-	Quick Ratio	1.00	Sales past 5Y	9.88%	Gross Margin	53.61%	52W Low	18.46%	ATR (14)	0.01
Dividend Ex-Date	-	Current Ratio	1.67	EPS Y/Y TTM	44.07%	Oper. Margin	-33.97%	RSI (14)	29.30	Volatility	19.22% 12.29%
Employees	26	Debt/Eq	0.83	Sales Y/Y TTM	12.04%	Profit Margin	-113.38%	Recom	1.00	Target Price	2.60
Option/Short	No / Yes	LT Debt/Eq	0.34	EPS Q/Q	81.16%	Payout	-	Rel Volume	0.44	Prev Close	0.07
Sales Surprise	9.62%	EPS Surprise	-343.33%	Sales Q/Q	2.31%	Earnings	Mar 26 AMC	Avg Volume	3.56M	Price	0.08
SMA20	-20.46%	SMA50	-39.04%	SMA200	-77.67%	Trades		Volume	1,564,470	Change	6.21%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-18-19	Initiated	Ladenburg Thalmann	Buy	$1.10
Jul-06-18	Reiterated	H.C. Wainwright	Buy	$4
Nov-15-17	Reiterated	Laidlaw	Buy	$10 → $8
Jun-05-17	Initiated	ROTH Capital	Buy	$5.50
Mar-27-17	Initiated	Laidlaw	Buy	$10
Feb-06-17	Initiated	Rodman & Renshaw	Buy	$6
Mar-07-16	Downgrade	Maxim Group	Buy → Hold
Dec-14-15	Reiterated	Maxim Group	Buy	$1 → $0.23
Apr-30-15	Resumed	Maxim Group	Buy	$2
Mar-06-13	Initiated	Ascendiant Capital Markets	Strong Buy	$2.25
Jan-03-08	Initiated	Dawson James	Speculative Buy	$8

Show Previous Ratings

Apr-22-24 06:57AM	NovaBay Pharmaceuticals Announces New and Enhanced Direct-to-Consumer Marketing to Efficiently Engage Customers and Drive Avenova Sales (Business Wire) -12.01%
Apr-19-24 06:00PM	NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder Equity (Business Wire)
Apr-17-24 06:59AM	NovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing Expenses (Business Wire)
Mar-27-24 11:28AM	NovaBay Pharmaceuticals, Inc. (AMEX:NBY) Q4 2023 Earnings Call Transcript (Insider Monkey) -19.99%
09:57AM	Q4 2023 NovaBay Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents)
04:05PM	Loading…
Mar-26-24 04:05PM	NovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial Results (Business Wire) +7.83%
Mar-25-24 06:38PM	NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024 (Business Wire) -5.36%
Mar-14-24 08:00AM	NovaBay Pharmaceuticals Announces Agreement to Sell its DERMAdoctor Skincare Business Segment; Announces Preliminary Financial Results for Fourth Quarter and Year Ended December 31, 2023 (Business Wire)
Mar-13-24 07:00AM	NovaBay Pharmaceuticals and Eyenovia to Co-Promote Prescription Ophthalmic Products to U.S. Eyecare Professionals (GlobeNewswire)
Jan-30-24 09:00AM	NovaBay Pharmaceuticals Reports 64% Year-Over-Year Growth in Avenova Unit Subscription-Based Sales (Business Wire) -9.34%
Jan-09-24 09:15AM	NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonomas Extensive Distributor Network (ACCESSWIRE)
Dec-06-23 06:50AM	NovaBay Pharmaceuticals Partners with Woo University to Educate Eyecare Professionals on the Use of Amniotic Membranes (Business Wire)
Nov-12-23 08:33AM	NovaBay Pharmaceuticals, Inc. (AMEX:NBY) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-09-23 04:05PM	NovaBay Pharmaceuticals Reports Third Quarter 2023 Financial Results (Business Wire) +5.73%
Nov-02-23 06:50AM	NovaBay Pharmaceuticals to Hold Third Quarter 2023 Conference Call on November 9, 2023 (Business Wire)
08:00AM	Loading…
Oct-11-23 08:00AM	NovaBay Pharmaceuticals Expands Physician Dispensed Sales Channel with New Avenova Programs (Business Wire)
Oct-02-23 06:50AM	NovaBay Pharmaceuticals to Present at the Dawson James Small Cap Growth Conference (Business Wire)
Sep-21-23 09:35AM	Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference (GlobeNewswire)
Sep-14-23 08:00AM	NovaBay Pharmaceuticals Announces Commercial Launch of Avenova® Allograft (Business Wire)
Sep-11-23 08:00AM	NovaBay Pharmaceuticals Announces Agreement with BioStem Technologies to Commercialize Amniotic Tissue Allograft as Avenova® Allograft (Business Wire) +11.45%
Aug-15-23 06:31AM	NovaBay Pharmaceuticals, Inc. (AMEX:NBY) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-11-23 06:44AM	Q2 2023 NovaBay Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents) -7.14%
Aug-10-23 04:05PM	NovaBay Pharmaceuticals Reports Second Quarter 2023 Financial Results (Business Wire) +6.10%
Aug-08-23 04:05PM	NovaBay Pharmaceuticals to Hold Second Quarter 2023 Conference Call on August 10, 2023 (Business Wire)
Jul-14-23 08:30AM	NovaBay Pharmaceuticals Reports Record Avenova Sales Day (Business Wire)
Jul-10-23 06:50AM	NovaBay Pharmaceuticals Announces Exclusive Amazon Prime Day 2023 Promotions on All Avenova-Branded Products (Business Wire) +5.18%
Jun-28-23 06:50AM	NovaBay Pharmaceuticals Supports National Dry Eye Awareness Month with Educational Programs and Avenova Product Promotions (Business Wire)
Jun-20-23 06:50AM	NovaBay Pharmaceuticals to Showcase its Full Line of Avenova Eyecare Products at the 126th Annual American Optometric Association Congress (Business Wire) +8.76%
Jun-12-23 06:50AM	NovaBay Pharmaceuticals Announces DERMAdoctors KP Duty Lotion and Scrub Ultra Duo Set for Dry, Rough, Bumpy Skin to be Featured on QVC at a Special Price (Business Wire) +5.87%
May-30-23 07:00AM	Presenting on the Emerging Growth Conference on May 31 Register Now (GlobeNewswire)
01:52PM	Loading…
May-29-23 01:52PM	NovaBay Pharmaceuticals looking to grow its three verticals of eye, skin, and wound care in 2023 (News Direct)
May-24-23 06:50AM	NovaBay Pharmaceuticals to Present at the Emerging Growth Virtual Conference on May 31, 2023 (Business Wire) -6.38%
May-11-23 04:05PM	NovaBay Pharmaceuticals Reports First Quarter 2023 Financial Results (Business Wire)
May-05-23 06:50AM	PhaseOne Health Collaborates with Nonprofit Humanitarian Organization to Supply NovaBay Pharmaceuticals Phase One® Skin and Wound Cleanser to Ukraine (Business Wire)
May-04-23 06:50AM	NovaBay Pharmaceuticals to Hold First Quarter 2023 Conference Call on May 11, 2023 (Business Wire)
May-01-23 06:50AM	NovaBay Pharmaceuticals Fulfills $1 Million Order for NeutroPhase® Skin and Wound Cleanser for China Pioneer Pharma Holdings (Business Wire)
Apr-27-23 04:47PM	NovaBay Pharmaceuticals Announces $3.0 Million Convertible Note Financing (Business Wire)
Apr-21-23 06:50AM	NovaBay Pharmaceuticals Launches DERMAdoctors New Comfort + Joy Psoriasis Therapeutic Moisturizing Cream on the QVC® Network (Business Wire)
Mar-30-23 04:06PM	NovaBay Pharmaceuticals Reports 2022 Fourth Quarter and Full Year Financial Results (Business Wire)
Mar-23-23 06:50AM	NovaBay Pharmaceuticals to Hold 2022 Fourth Quarter and Full Year Conference Call on March 30, 2023 (Business Wire)
Mar-14-23 06:50AM	Eyeganics Organic Tears, the Only USDA-Certified Organic Lubricant Eye Drop, Now Available through NovaBay Pharmaceuticals Avenova.com and Physician-Dispensed Channel (Business Wire)
Mar-07-23 06:50AM	NovaBay Pharmaceuticals Launches Avenova® Eye Health Support, a New Antioxidant-Rich Oral Supplement to Comfort Dry Eyes and Promote Overall Eye Health (Business Wire) -6.02%
Feb-06-23 06:50AM	NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin to Discuss DERMAdoctors Eczema Treatment on Two QVC® Shows on February 7 (Business Wire)
Jan-31-23 06:50AM	NovaBay Pharmaceuticals to Present at the Virtual Sequire Biotechnology Conference on February 2, 2023 (Business Wire)
Jan-17-23 06:50AM	PhaseOne Health and NovaBay Pharmaceuticals to Expand Commercial and Collaborative Strategies for the Wound Care Market (Business Wire)
Nov-29-22 06:50AM	NovaBay Pharmaceuticals Announces the Launch of DERMAdoctors TikTok Store in China and Expands Online Marketing in the U.S. and China (Business Wire)
Nov-17-22 06:50AM	NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin Returns to the QVC® Network With DERMAdoctors Eczema Balm (Business Wire) -9.32%
Nov-14-22 04:05PM	NovaBay Pharmaceuticals Reports Third Quarter 2022 Financial Results (Business Wire)
04:02PM	NovaBay Pharmaceuticals Announces 1-for-35 Reverse Stock Split (Business Wire)
Nov-09-22 04:05PM	NovaBay Pharmaceuticals to Hold Third Quarter 2022 Conference Call on November 14 (Business Wire) -9.51%
Oct-26-22 06:50AM	NovaBay Pharmaceuticals Announces Expansion of DERMAdoctor Picture Porefect Collection with Launch of 15% Niacinamide Pore Minimizing Serum (Business Wire) +11.89%
Oct-19-22 06:50AM	NovaBay Pharmaceuticals to Present at the LD Micro Main Event XV (Business Wire)
Oct-18-22 06:50AM	NovaBay Pharmaceuticals Announces Significant Orders for DERMAdoctors Top-Selling Kakadu C Anti-Aging Serum ahead of the Holiday Season (Business Wire)
Oct-10-22 06:50AM	NovaBay Pharmaceuticals Avenova® and DERMAdoctor® Products to be Featured During the October 11-12 Amazon Prime Early Access Sale (Business Wire)
Oct-07-22 04:05PM	NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Low Share Price (Business Wire) -6.27%
Sep-23-22 06:50AM	NovaBay Pharmaceuticals to Present at the Ladenburg Thalmann 2022 Healthcare Conference (Business Wire) -8.86%
Sep-22-22 04:05PM	NovaBay Pharmaceuticals CEO Issues Letter to Stockholders (Business Wire)
Sep-16-22 08:35AM	Life Sciences Virtual Investor Conference: Presentations Now Available for On-Demand Viewing (GlobeNewswire) -5.53%
Sep-13-22 06:50AM	NovaBay Pharmaceuticals to Present at the Virtual Life Sciences Investor Forum (Business Wire)
Sep-12-22 08:35AM	Life Sciences Virtual Investor Conference Agenda Announced for September 15th (GlobeNewswire)
06:50AM	NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin to Showcase DERMAdoctors Eczema Balm on Return QVC® Appearance (Business Wire)
Sep-09-22 08:00AM	NovaBay Pharmaceuticals Enters Into Agreements For a Private Placement and Warrant Reprice Transactions To Raise Up to $5.3 Million (Business Wire) -13.03%
Aug-11-22 04:30PM	Edited Transcript of NBY.A earnings conference call or presentation 11-Aug-22 8:30pm GMT (Thomson Reuters StreetEvents)
04:05PM	NovaBay Pharmaceuticals Reports Second Quarter 2022 Financial Results (Business Wire)
Aug-04-22 06:50AM	NovaBay Pharmaceuticals to Hold Second Quarter 2022 Conference Call on August 11 (Business Wire)
Jul-28-22 06:50AM	NovaBay Pharmaceuticals Targets New Market with Antimicrobial Avenova® Lid and Lash Spray for Lash Extensions (Business Wire)
Jul-21-22 06:50AM	NovaBay Pharmaceuticals DERMAdoctor Products Now Available at Target.com and Urbanoutfitters.com (Business Wire)
Jul-15-22 06:50AM	NovaBay Pharmaceuticals Reports Record Avenova® Sales During Amazons Prime Day Event (Business Wire)
Jul-07-22 06:50AM	NovaBay Pharmaceuticals DERMAdoctor Products to be Featured at Leading B2B Beauty Trade Show Cosmoprof North America (Business Wire) +6.90%
May-12-22 04:05PM	NovaBay Pharmaceuticals Reports First Quarter 2022 Financial Results (Business Wire)
May-09-22 06:50AM	NovaBay Pharmaceuticals Expands Top-Selling DERMAdoctor Kakadu C and Calm Cool + Corrected Collections with New Anti-Aging Formulations (Business Wire) -11.60%
May-05-22 06:50AM	NovaBay Pharmaceuticals to Hold First Quarter 2022 Conference Call on May 12 (Business Wire)
Apr-25-22 06:50AM	NovaBay Pharmaceuticals CEO Issues Letter to Stockholders (Business Wire)
Apr-11-22 06:50AM	NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin Returns to QVC® to Discuss DERMAdoctors Eczema Treatment (Business Wire)
Apr-01-22 06:50AM	NovaBay Pharmaceuticals Introduces Hydrating Cleansing Oil to its DERMAdoctor Calm Cool + Corrected Product Line (Business Wire)
Mar-29-22 04:05PM	NovaBay Pharmaceuticals Reports 2021 Fourth Quarter and Full Year Financial Results (Business Wire)
Mar-22-22 06:50AM	NovaBay Pharmaceuticals to Hold 2021 Fourth Quarter and Full Year Conference Call on March 29 (Business Wire)
Mar-17-22 07:00PM	NioBay Metals suspends exploration at the James Bay Niobium Project (GlobeNewswire) +5.51%
Mar-09-22 06:50AM	DERMAdoctor Launches New HA Serum to Expand Calm Cool + Corrected Product Line (Business Wire)
Feb-28-22 06:50AM	NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin to Present DERMAdoctor Eczema Treatment as QVC® On-Air Guest (Business Wire)
Feb-23-22 06:50AM	NovaBay Pharmaceuticals Engages Leading Chinese Marketing Firm to Drive Consumer Sales of DERMAdoctor Skincare Products in China (Business Wire)
Jan-28-22 06:50AM	NovaBay Pharmaceuticals Announces Changes to Its Board of Directors (Business Wire)
Jan-20-22 06:52AM	NovaBay Pharmaceuticals to Donate 2.5 Million KN95 Masks (Business Wire)
06:50AM	NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders (Business Wire)
Jan-10-22 06:50AM	NovaBay Pharmaceuticals Expands Its Eyecare Product Portfolio With the Launch of Lubricating Eye Drops for the Immediate Relief of Dry Eye Symptoms (Business Wire)
Jan-04-22 06:50AM	NovaBay Pharmaceuticals to Present at H.C. Wainwright BioConnect Virtual Conference (Business Wire)
Dec-21-21 06:50AM	NovaBay Pharmaceuticals Holds Special Meeting of Stockholders (Business Wire)
Dec-13-21 10:59AM	DERMAdoctors Calm Cool + Corrected Eczema Balm Receives National Eczema Association Seal of Acceptance (Business Wire) -15.50%
Nov-18-21 06:50AM	NovaBay Pharmaceuticals CEO Issues Letter to Stockholders (Business Wire) -6.78%
Nov-11-21 04:05PM	NovaBay Pharmaceuticals Reports Third Quarter 2021 Financial Results (Business Wire)
Nov-08-21 06:50AM	NovaBay Pharmaceuticals Closes DERMAdoctor Acquisition (Business Wire)
Nov-03-21 06:50AM	NovaBay Pharmaceuticals Closes $15.0 Million Private Placement (Business Wire) +18.82%
Nov-01-21 08:30AM	NovaBay Pharmaceuticals Announces Pricing of $15.0 Million Private Placement (Business Wire)
Sep-29-21 06:50AM	NovaBay Pharmaceuticals to Hold Conference Call and Webcast With Slide Presentation Today to Discuss Acquisition of DERMAdoctor (Business Wire) -6.72%
Sep-28-21 08:00AM	NovaBay Pharmaceuticals Signs Agreement to Acquire DERMAdoctor (Business Wire)
Sep-08-21 06:50AM	NovaBay Pharmaceuticals to Present at the H.C. Wainwright 23nd Annual Global Investment Conference (Business Wire)
Aug-19-21 06:50AM	NovaBay Pharmaceuticals to Distribute Zocular® Dry Eye Products (Business Wire)
Aug-12-21 04:05PM	NovaBay Pharmaceuticals Reports Second Quarter 2021 Financial Results (Business Wire)
Aug-05-21 06:50AM	NovaBay Pharmaceuticals to Hold Second Quarter 2021 Conference Call on August 12 (Business Wire)
Jul-19-21 08:00AM	NovaBay Pharmaceuticals Partners with Harrow Healths ImprimisRx® to Promote Prescription Avenova (Business Wire) +16.02%

NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. Its products include Avenova, NeutroPhase, CelleRx, and DERMAdoctor. The company was founded on January 19, 2000 and is headquartered in Emeryville, CA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NBY

Novabay Pharmaceuticals Inc

Upgrade your FINVIZ experience